Physician profile
Michael J Gordon
NPI 1376584615
$14,639.26
in general payments reported to CMS, 2019-2025
20 companies · $2,214 in 2025
The $2,214 reported for 2025 was more than what 84% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $883 · 2020: $345 · 2021: $226 · 2022: $8,197 · 2023: $2,303 · 2024: $470 · 2025: $2,214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,203 · Travel and Lodging: $1,635 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,203.19 |
| Travel and Lodging | $1,634.99 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $5,953.28 | 2019-2024 | Xiaflex |
| Arthrex, INC. | $5,249.88 | 2019-2025 | |
| Coastal Medical Technologies LLC | $877.67 | 2023-2025 | |
| Axogen | $582.13 | 2022-2023 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Stryker Corporation | $396.71 | 2019-2024 | Mako |
| Mvp Orthopedics INC | $286.09 | 2021-2022 | |
| Bioventus LLC | $215.87 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $197.27 | 2024 | Intellis Adaptivestim |
| Zimmer Biomet Holdings, INC. | $185.68 | 2023-2024 | Persona, Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $153.62 | 2020-2023 | Na |
| Amgen INC. | $121.86 | 2019 | |
| Bridgebio Pharma, INC. | $121.34 | 2025 | Attruby |
| Endo USA, INC. | $120.53 | 2024-2025 | Xiaflex |
| Smith+Nephew, INC. | $57.02 | 2019-2022 | |
| Si-Bone, INC. | $41.22 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heraeus Medical, LLC. | $19.27 | 2020-2021 | |
| Pacira Therapeutics, INC. | $18.64 | 2020 | |
| Ermi LLC | $16.25 | 2021 | |
| Theragen, INC. | $13.02 | 2020 | |
| Fidia Pharma USA INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.